A review by US regulators of the single-shot Johnson & Johnson coronavirus vaccine has found it is safe and effective.
It paves the way for it to become the third Covid-19 vaccine to be authorised in the US, possibly within days.
The vaccine would be a cost-effective alternative to the Pfizer and Moderna vaccines, and can be stored in a refrigerator instead of a freezer.
The Belgian company Janssen, which is owned by the pharmaceutical giant, said its data showed the product was highly effective against severe disease.
It comes as Ghana became the first country to receive coronavirus vaccines through the Covax vaccine-sharing initiative.
The briefing document published by the US Food and Drug Administration (FDA) gives more detail on the data submitted by Janssen to the regulator. The FDA concludes that the Johnson & Johnson vaccine has "known benefits" in reducing both symptomatic and severe illness.
Results from vaccine trials conducted in the US, South Africa and Brazil found its efficacy against the worst outcomes of the virus was "similarly high" but overall protection was lower in South Africa and Brazil, where virus variants have become dominant.
Data showed it was more than 85% effective at preventing serious illness, but only 66% effective overall, when moderate cases were included, when considering cases at least 28 days after vaccination.
Notably, there were no deaths among participants who had received the vaccine and no hospital admissions after 28 days post-vaccine.
An external committee of experts will meet on Friday to recommend whether the FDA should authorise the vaccine, possibly adding to a coming surge in vaccine availability in the US.
A White House official said the administration anticipated distributing at least three million doses of the Johnson & Johnson vaccine next week, should it receive emergency authorisation from the FDA.
The company says it plans to deliver 20 million doses in total by late March, in line with an agreement to supply the US with 100m doses by the end of June.
Latest Stories
-
World Bank’s food price index eases; maize, wheat prices hit 3-year low
44 mins -
2020 polls all about pulling Ghana back from precipice of destruction, corruption – Naana Jane
48 mins -
Guru expresses interest in contesting SRC election at UG
55 mins -
Oil prices projected to average $84 in 2024 – World Bank
1 hour -
Meet 2 Ghanaian entrepreneurs on a mission to connect 1m African professionals to global companies by 2034
2 hours -
NCA approves Starlink’s satellite broadband application
2 hours -
Government orders FGR to revamp mining operations; assures workers of commitment to their welfare
2 hours -
Arne Slot philosophy could suit Liverpool – Van Dijk
2 hours -
EC replies Mahama: You also appointed someone who was tagged NDC
2 hours -
See colourful outdoor of Prof Naana Opoku-Agyemang as NDC’s running mate
2 hours -
Akufo-Addo commissions 15MWP Kaleo Solar Power Plant
3 hours -
GCB Bank PLC leads African financial integration, hosts ZICB delegation
3 hours -
Empowering Girls in ICT: FAWE Ghana advocates for gender equality in the Tech sector
4 hours -
Rangnick ‘contacted by Bayern Munich’ about manager job
4 hours -
Winneba Youth Choir celebrates 35th Anniversary with Aseda Concert sponsored by Fidelity Bank
4 hours